Impact of single centre kidney-exchange transplantation to increase living donor pool in India: A cohort study involving non-anonymous allocation.

IF 2.4 4区 医学 Q2 UROLOGY & NEPHROLOGY Nephrology Pub Date : 2024-12-01 Epub Date: 2024-09-08 DOI:10.1111/nep.14380
Vivek B Kute, Himanshu V Patel, Subho Banerjee, Divyesh P Engineer, Ruchir B Dave, Nauka Shah, Sanshriti Chauhan, Harishankar Meshram, Priyash Tambi, Akash Shah, Khushboo Saxena, Manish Balwani, Vishal Parmar, Shivam Shah, Ved Prakash, Sudeep Patel, Dev Patel, Sudeep Desai, Jamal Rizvi, Harsh Patel, Beena Parikh, Kamal Kanodia, Shruti Gandhi, Michael A Rees, Alvin E Roth, Pranjal Modi
{"title":"Impact of single centre kidney-exchange transplantation to increase living donor pool in India: A cohort study involving non-anonymous allocation.","authors":"Vivek B Kute, Himanshu V Patel, Subho Banerjee, Divyesh P Engineer, Ruchir B Dave, Nauka Shah, Sanshriti Chauhan, Harishankar Meshram, Priyash Tambi, Akash Shah, Khushboo Saxena, Manish Balwani, Vishal Parmar, Shivam Shah, Ved Prakash, Sudeep Patel, Dev Patel, Sudeep Desai, Jamal Rizvi, Harsh Patel, Beena Parikh, Kamal Kanodia, Shruti Gandhi, Michael A Rees, Alvin E Roth, Pranjal Modi","doi":"10.1111/nep.14380","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>In India, 85% of organ donations are from living donors and 15% are from deceased donors. One-third of living donors were rejected because of ABO or HLA incompatibility. Kidney exchange transplantation (KET) is a cost-effective and legal strategy to increase living donor kidney transplantation (LDKT) by 25%-35%.</p><p><strong>Methods: </strong>We report our experience with 539 KET cases and the evolution of a single-centre program to increase the use of LDKT.</p><p><strong>Results: </strong>Between January 2000 and 13 March, 2024, 1382 deceased donor kidney transplantations and 5346 LDKT were performed at our centre, including 10% (n = 539) from KET. Of the 539 KET, 80.9% (n = 436) were ABO incompatible pairs, 11.1% (n = 60) were compatible pairs, and 8% (n = 43) were sensitized pairs. There were 75% 2-way (n = 2 × 202 = 404), 16.2% 3-way (n = 3 × 29 = 87), 3% 4-way (n = 4 × 4 = 16), 1.8% 5-way (n = 5 × 2 = 10), 2.2% 6-way (n = 6 × 2 = 12), and 1.8% 10-way KET (n = 10 × 1 = 10). Of the recipients 81.2% (n = 438) were male and 18.8% (n = 101) were female, while of the donors, 78.5% (n = 423) were female and 21.5% (n = 116) were male. All donors were near relatives; wives (54%, n = 291) and mothers (20%, n = 108) were the most common donors. At a median follow-up of 8.2 years, patient survival, death censored graft survival, acute rejection, and median serum creatinine levels of functioning grafts were 81.63% (n = 440), 91% (n = 494), 9.8% (n = 53) and 1.3 mg/dL respectively. We credited the success to maintaining a registry of incompatible pairs, high-volume LDKT programs, non-anonymous allocation and teamwork.</p><p><strong>Conclusion: </strong>This is the largest single-centre KET program in Asia. We report the challenges and solutions to replicate our success in other KET programs.</p>","PeriodicalId":19264,"journal":{"name":"Nephrology","volume":" ","pages":"917-929"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/nep.14380","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/8 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: In India, 85% of organ donations are from living donors and 15% are from deceased donors. One-third of living donors were rejected because of ABO or HLA incompatibility. Kidney exchange transplantation (KET) is a cost-effective and legal strategy to increase living donor kidney transplantation (LDKT) by 25%-35%.

Methods: We report our experience with 539 KET cases and the evolution of a single-centre program to increase the use of LDKT.

Results: Between January 2000 and 13 March, 2024, 1382 deceased donor kidney transplantations and 5346 LDKT were performed at our centre, including 10% (n = 539) from KET. Of the 539 KET, 80.9% (n = 436) were ABO incompatible pairs, 11.1% (n = 60) were compatible pairs, and 8% (n = 43) were sensitized pairs. There were 75% 2-way (n = 2 × 202 = 404), 16.2% 3-way (n = 3 × 29 = 87), 3% 4-way (n = 4 × 4 = 16), 1.8% 5-way (n = 5 × 2 = 10), 2.2% 6-way (n = 6 × 2 = 12), and 1.8% 10-way KET (n = 10 × 1 = 10). Of the recipients 81.2% (n = 438) were male and 18.8% (n = 101) were female, while of the donors, 78.5% (n = 423) were female and 21.5% (n = 116) were male. All donors were near relatives; wives (54%, n = 291) and mothers (20%, n = 108) were the most common donors. At a median follow-up of 8.2 years, patient survival, death censored graft survival, acute rejection, and median serum creatinine levels of functioning grafts were 81.63% (n = 440), 91% (n = 494), 9.8% (n = 53) and 1.3 mg/dL respectively. We credited the success to maintaining a registry of incompatible pairs, high-volume LDKT programs, non-anonymous allocation and teamwork.

Conclusion: This is the largest single-centre KET program in Asia. We report the challenges and solutions to replicate our success in other KET programs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单中心肾脏交换移植对增加印度活体供体库的影响:一项涉及非匿名分配的队列研究。
目的:在印度,85% 的器官捐献者是活体捐献者,15% 是已故捐献者。三分之一的活体捐献者因 ABO 或 HLA 不相容而被拒绝。肾脏交换移植(KET)是一种成本效益高且合法的策略,可将活体肾脏移植(LDKT)率提高25%-35%:方法:我们报告了 539 例 KET 的经验,以及单中心计划提高 LDKT 使用率的演变过程:结果:2000年1月至2024年3月13日期间,我们中心共进行了1382例死体肾移植和5346例LDKT,其中10%(n = 539)来自KET。在 539 例 KET 中,80.9%(n = 436)为 ABO 不相容配对,11.1%(n = 60)为相容配对,8%(n = 43)为致敏配对。其中,75%为2对(n = 2 × 202 = 404),16.2%为3对(n = 3 × 29 = 87),3%为4对(n = 4 × 4 = 16),1.8%为5对(n = 5 × 2 = 10),2.2%为6对(n = 6 × 2 = 12),1.8%为10对KET(n = 10 × 1 = 10)。在受者中,81.2%(n = 438)为男性,18.8%(n = 101)为女性,而在捐献者中,78.5%(n = 423)为女性,21.5%(n = 116)为男性。所有捐献者都是近亲;妻子(54%,n = 291)和母亲(20%,n = 108)是最常见的捐献者。中位随访时间为 8.2 年,患者存活率、死亡剔除移植物存活率、急性排斥反应和功能正常移植物的中位血清肌酐水平分别为 81.63%(n = 440)、91%(n = 494)、9.8%(n = 53)和 1.3 mg/dL。我们将这一成功归功于不相容配对登记、高容量 LDKT 项目、非匿名分配和团队合作:这是亚洲最大的单中心 KET 项目。我们报告了在其他 KET 项目中复制我们的成功所面临的挑战和解决方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Nephrology
Nephrology 医学-泌尿学与肾脏学
CiteScore
4.50
自引率
4.00%
发文量
128
审稿时长
4-8 weeks
期刊介绍: Nephrology is published eight times per year by the Asian Pacific Society of Nephrology. It has a special emphasis on the needs of Clinical Nephrologists and those in developing countries. The journal publishes reviews and papers of international interest describing original research concerned with clinical and experimental aspects of nephrology.
期刊最新文献
A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture. Long-Term Clinical Outcomes of Paediatric Kidney Transplantation in Hong Kong-A Territory-Wide Study. VDAC1 Cleavage Promotes Autophagy in Renal Tubular Epithelial Cells With Hypoxia/Reoxygenation Injury. Pegcetacoplan for the Treatment of Paediatric C3 Glomerulonephritis: A Case Report. Epiberberine Improves Hyperglycemia and Ameliorates Insulin Sensitivity in Type 2 Diabetic Mice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1